Source by www.The-Independent.com
A biology teacher became the UK's first multiple sclerosis patient to receive CAR T-cell therapy. The treatment genetically reprograms her own immune cells to target MS-causing B cells. Emily Henders received the three-minute infusion at University College London Hospital. She reports feeling normal with renewed energy following the procedure.
The therapy aims to provide long-term remission with a single treatment. This approach could potentially eliminate the need for ongoing medication. Doctors hope it will transform MS treatment by halting disease progression.
